Skip to main content
Clinical Trials/NCT01700205
NCT01700205CompletedNot Applicable

Impact of Diet Composition on Energy Balance and Satiety During Infancy

Monell Chemical Senses Center1 site in 1 country113 target enrollmentStarted: November 2, 2012Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
113
Locations
1
Primary Endpoint
Growth: Length for Age (LAZ) Z Scores

Study Overview

Brief Summary

The overarching goal of the research we propose here is to conduct a randomized clinical trial to specify the physiologic and behavioral mechanisms by which infant-formula composition affects all aspects of energy balance and growth during the first years of life.

Detailed Description

This is a randomized clinical trial of infants whose parents decided to formula feed them; mother-infant dyads will be randomized when infant is 2 weeks of age to one of 2 groups. The groups will differ in the composition of the formula fed to the infant during the first year of life.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Other
Masking
Triple (Participant, Care Provider, Outcomes Assessor)

Eligibility Criteria

Ages
1 Week to 3 Weeks (Child)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •A healthy, term (≥37 and ≤42 week gestation at birth), singleton infant.
  • •Birth weight between 2500 - 4500 grams.
  • •At the time of enrollment, infant must be ≤14 days old (Date of birth=day 0).
  • •Mother must be 18 years or older.
  • •Infant must be consuming a standard cow's milk protein infant formula and have been receiving a standard cow's milk protein infant formula for at least the past 2 days prior to enrollment.

Exclusion Criteria

  • •Mother had gestational diabetes during pregnancy
  • •Infant has condition requiring infant feedings other than feeding cow milk formula from a bottle.
  • •Infant has major congenital malformations (i.e. cleft palate, hemangiomas, extremity malformation).
  • •Infant has suspected or documented systemic or congenital infections (e.g., human immunodeficiency virus, cytomegalovirus).
  • •Infant has evidence of significant cardiac, respiratory, endocrinologic, hematologic, gastrointestinal, or other systemic diseases. For example, infant must not be receiving insulin or growth hormone.
  • •Dyad be the relative (son, daughter, niece, nephew, cousin, aunt, uncle, sibling) of ancillary personnel connected with the study.

Arms & Interventions

Type of Formula: CMF

Active Comparator

Infants are randomized to feed standard cow milk formula during first year of life

Intervention: Type of Formula (Other)

Type of Formula: EHF

Experimental

Infants are randomized to feed extensively hydrolyzed infant formula during first year of life

Intervention: Type of Formula (Other)

Outcomes

Primary Outcomes

Growth: Length for Age (LAZ) Z Scores

Time Frame: 0.5 to 12.5 months with followup visit at 18.5 mos

At each visit, infants were measured to monitor normal growth. These anthropometric data were converted to Length for age Z (LAZ) Z scores using World Health Organization (WHO) growth standards. The Z-score expresses the anthropometric value as a number of standard deviations or Z-scores below or above the reference mean value. Normal range for Z score is -2.0 (minimum) to 2.0 (maximum).

Energy Balance: Energy Intake From Infant Formula and Other Sources

Time Frame: 0.75, 3.5, 12.5 mos

Energy intake (kcal/day) of infant formula and other sources was determined by three-day weighed bottle intake and records of the infants' intake of any liquid or food other than formula during the three days

Growth, Weight for Age (WAZ) Z Score

Time Frame: 0.5 to 12.5 months with followup visit at 18.5 mos

At each visit, infants were weighed to monitor normal growth. These anthropometric data were converted to Weight for age Z (WAZ) Z scores using World Health Organization (WHO) growth standards. The Z-score expresses the anthropometric value as a number of standard deviations or Z-scores below or above the reference mean value. Normal range for Z score is -2.0 (minimum) to 2.0 (maximum).

Energy Balance: Energy Loss in Stools

Time Frame: 0.75, 3.5, 12.5 mos

Stool EL (kcal/day) was determined from 3-day stool collection by bomb calorimetry at each timepoint

Growth, Weight for Length (WLZ) Z Scores

Time Frame: 0.5 to 12.5 months with followup visit at 18.5 mos

At each visit, infants were weighed and measured to monitor normal growth. These anthropometric data were converted to weight-for-length (WLZ) Zscores using World Health Organization (WHO) growth standards. The Z-score expresses the anthropometric value as a number of standard deviations or Z-scores below or above the reference mean value. Normal range for Z score is -2.0 (minimum) to 2.0 (maximum).

Energy Balance: Sleeping Energy Expenditure (SEE)

Time Frame: 0.75, 3.5, 12.5 mos

Postprandial SEE (kcal/day), a proxy for resting energy expenditure in infant, was measured for a minimum of 30 min by open-circuit, indirect calorimetry using a metabolic cart with canopy hood, in a quiet, thermal-neutral room.

Energy Balance: Total Energy Expenditure (TEE)

Time Frame: 0.75, 3.5, 12.5 mos

TEE (kcal/day) was measured over 7 days at each of the three time points (0.75, 3.5 and12.5 mos) using the doubly labeled water method

Secondary Outcomes

  • Feeding Behaviors, Maternal Perceptions(0.5 months)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Julie A. Mennella, PhD

Member

Monell Chemical Senses Center

Study Sites (1)

Loading locations...

Similar Trials